Aurinia製藥 AUPH 深 滬
已收盤 09-20 16:00:00 美东时间
7.20
0.000
0.00%
華盛通- 最 高7.315
- 今 開7.18
- 成交量 296.50万股
- 最 低 7.15
- 昨 收 7.20
- 總市值 10.44亿
- 52周最高 10.05
- 市盈率 靜 --
- 換手率 2.04%
- 52周最低 4.71
- 委 比 26.69%
- 總股本 1.45亿
- 歷史最高 33.972
- 量 比 2.26
- 振 幅 2.29%
- 歷史最低 1.41
- 每 手 1
- 風險率 1.40%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Aurinia Pharmaceuticals shares gain as co reports Board restructuring
Aurinia Pharmaceuticals (NASDAQ:AUPH) gained in extended trading on Thursday after the company said that it has restructured its Board of Directors. Peter Greenleaf, President and Chief Executive Offi...
09-13 13:24
Aurinia Pharmaceuticals Announces Board Restructuring and Director Changes
The latest announcement is out from Aurinia Pharmaceuticals ( ($AUPH) ). Aurini...
09-13 04:30
快讯 | 唐资本管理报告于9月6日拥有Aurinia Pharmaceuticals Inc的5.1%持股 - SEC备案
Tang Capital Management Reports 5.1% Stake in Aurinia Pharmaceuticals Inc as of...
09-13 04:15
HC Wainwright & Co. Reiterates Buy on Aurinia Pharmaceuticals, Maintains $13 Price Target
HC Wainwright & Co. analyst Ed Arce reiterates Aurinia Pharmaceuticals (NASDAQ:AUPH) with a Buy and maintains $13 price target.
09-06 17:38
This Insider Has Just Sold Shares In Aurinia Pharmaceuticals
We note that the Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Chief Commercial Of...
08-14 03:04
快讯 | Aurinia Pharmaceuticals Inc: Leerink Partners将目标价从15美元降至11美元
Aurinia Pharmaceuticals Inc : Leerink Partners Cuts Target Price to $11 From $15
08-02 15:24
Aurinia Pharmaceuticals: Strong Q2 Sales and Market Penetration Back Buy Rating
In a report released today, Stacy Ku from TD Cowen maintained a Buy rating on A...
08-01 22:45
Aurinia Pharma beats Q2 estimates, narrows FY revenue guidance
Aurinia Pharma press release (NASDAQ:AUPH): Q2 GAAP EPS of $0.01 in-line. Revenue of $57.2M (+37.9% Y/Y) beats by $2.51M. Shares +2.72% PM. Company narrows 2024 net product revenue guidance range to $...
08-01 18:05
快讯 | Aurinia制药公司 - 将2024年的净产品营业收入指导区间缩小至2.1亿到2.2亿美元
Aurinia Pharmaceuticals Inc - Narrows 2024 Net Product Revenue Guidance Range t...
08-01 18:03
Aurinia Pharmaceuticals Q2 2024 GAAP EPS $0.01, Inline, Sales $57.200M Beat $55.055M Estimate
Aurinia Pharmaceuticals (NASDAQ:AUPH) reported quarterly earnings of $0.01 per share which met the analyst consensus estimate. The company reported quarterly sales of $57.200 million which beat the analyst consensus
08-01 18:02
